Di Giannuario A, Pieretti S, Sagratella S, Loizzo A
Laboratorio di Farmacologia, Istituto Superiore di Sanità, Rome, Italy.
Neuropsychobiology. 2001;43(3):213-20. doi: 10.1159/000054892.
Previous data indicate that intracerebroventricular administration of agonists for mu- and delta-opioid receptors induces limbic seizures in rats, but no data are reported in rabbits. We found that the mu- and delta-opioid peptides [D-Ala(2)-N,Me-Phe(4)-Gly(5)-ol]enkephalin (DAMGO), beta-endorphin and deltorphin II, induced EEG non-convulsive hippocampal seizures, and changes in hippocampal background EEG, physical parameters and overt behaviour after central administration. Dexamethasone pre-treatment prevented DAMGO-, deltorphin II- and beta-endorphin-induced seizures as well as changes in background EEG, physical parameters and overt behaviour induced by mu-opioid agonists. Dexamethasone antagonism on opioid action was blocked by pre-treatment with a protein synthesis inhibitor, cycloheximide or by the kappa-opioid antagonist nor-binaltorphimine. Our data suggest that dexamethasone influences opioid actions at mu- and delta-receptors via a protein synthesis mechanism involving kappa-opioid receptors.
先前的数据表明,向大鼠脑室内注射μ-和δ-阿片受体激动剂会诱发边缘性癫痫发作,但在兔子中未报道相关数据。我们发现,μ-和δ-阿片肽[D-丙氨酸(2)-N-甲基苯丙氨酸(4)-甘氨酸(5)-醇]脑啡肽(DAMGO)、β-内啡肽和强啡肽II,在中枢给药后会诱发脑电图非惊厥性海马癫痫发作,以及海马背景脑电图、身体参数和明显行为的变化。地塞米松预处理可预防DAMGO、强啡肽II和β-内啡肽诱发的癫痫发作,以及μ-阿片激动剂诱发的背景脑电图、身体参数和明显行为的变化。用蛋白质合成抑制剂环己酰亚胺预处理或κ-阿片拮抗剂nor-binaltorphimine可阻断地塞米松对阿片类药物作用的拮抗作用。我们的数据表明,地塞米松通过涉及κ-阿片受体的蛋白质合成机制影响μ-和δ-受体处的阿片类药物作用。